Counterfeit pharma networks are becoming more sophisticated—leveraging advanced packaging, fragmented logistics, and global ...

Cheryl Allen, BS Pharm, MBA, founding partner, Curatio Scientia Advisors, discusses how the convergence of patient access ...

In addition, many adults (67%) also think policymakers should keep access- and coverage-related factors in mind, namely ...

In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more.

As the FDA ends its phased exemption period for most trading partners, Two Labs’ Michael Rowe warns that DSCSA compliance is ...

Various agreements with the Trump administration could have long-term ramifications for Medicaid access and global pricing strategy.

In today’s Pharma Pulse, the University of Maryland expands its medical class to combat physician shortages and much more.

The 20th installment of Trade & Channel Strategies carried on with a focus on boosting access to medication.

In today’s Pharma Pulse, new trials confirm AI chatbots are a successful and sustainable tool for increasing pneumococcal ...

The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...

Jay McHarg, CEO of AeroSafe Global, discusses the significance of rethinking the “last mile” as the first moment of patient care—using real-time Active Delivery Management—for proactive and improved ...

Having said that, Roth centered this morning’s keynote on “Navigating Disruption in the Pharmaceutical Channels,” a ...